{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:57:52Z","timestamp":1790193472203,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177103","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T23:06:42Z","timestamp":1730934402000},"page":"177103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Unleashing the future: The revolutionary role of machine learning and artificial intelligence in drug discovery"],"prefix":"10.1016","volume":"985","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3219-0171","authenticated-orcid":false,"given":"Manoj Kumar","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish Kumar","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navaneet","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Rashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabinda","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Samuel","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/13696998.2024.2315864","article-title":"Insights into artificial intelligence utilisation in drug discovery","volume":"27","author":"Abou Hajal","year":"2024","journal-title":"J. Med. Econ."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177103_bib2","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1080\/07391102.2022.2060308","article-title":"Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study","volume":"41","author":"Ahmad","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"16","key":"10.1016\/j.ejphar.2024.177103_bib3","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1021\/jacs.2c13467","article-title":"Generative models as an emerging paradigm in the chemical sciences","volume":"145","author":"Anstine","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177103_bib4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/biomedinformatics3040070","article-title":"Transforming drug design: innovations in computer-aided discovery for biosimilar agents","volume":"3","author":"Askari","year":"2023","journal-title":"BioMedInformatics"},{"key":"10.1016\/j.ejphar.2024.177103_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ab.2016.06.025","article-title":"Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis","volume":"508","author":"Aykul","year":"2016","journal-title":"Anal. Biochem."},{"issue":"6557","key":"10.1016\/j.ejphar.2024.177103_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a three-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177103_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4236\/ojms.2014.44022","article-title":"Hadoop and its role in modern image processing","volume":"4","author":"Banaei","year":"2014","journal-title":"Open J. Mar. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"49","key":"10.1016\/j.ejphar.2024.177103_bib9","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1021\/acs.jpcb.3c05521","article-title":"Graph neural networks and structural information on ionic liquids: a cheminformatics study on molecular physicochemical property prediction","volume":"127","author":"Baran","year":"2023","journal-title":"J. Phys. Chem. B"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177103_bib10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.drudis.2020.11.037","article-title":"Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data","volume":"26","author":"Bender","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10462-023-10669-z","article-title":"A review on graph neural networks for predicting synergistic drug combinations","volume":"57","author":"Besharatifard","year":"2024","journal-title":"Artif. Intell. Rev."},{"issue":"8","key":"10.1016\/j.ejphar.2024.177103_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2023.103694","article-title":"What is the rate of text generated by artificial intelligence over a year of publication in Orthopedics & Traumatology: surgery & Research? Analysis of 425 articles before versus after the launch of ChatGPT in November 2022","volume":"109","author":"Bisi","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"issue":"6","key":"10.1016\/j.ejphar.2024.177103_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ph16060891","article-title":"The role of AI in drug discovery: challenges, opportunities, and strategies","volume":"16","author":"Blanco-Gonz\u00e1lez","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.ejphar.2024.177103_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/omi.2015.0088","article-title":"Tissue-specific molecular biomarker signatures of type 2 diabetes: an integrative analysis of transcriptomics and protein-protein interaction data","volume":"19","author":"Calimlioglu","year":"2015","journal-title":"OMICS"},{"issue":"7","key":"10.1016\/j.ejphar.2024.177103_bib15","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.cell.2018.05.015","article-title":"Next-generation machine learning for biological networks","volume":"173","author":"Camacho","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177103_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bph.13798","article-title":"Drug repurposing from the perspective of pharmaceutical companies","volume":"175","author":"Cha","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177103_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.omtn.2023.02.019","article-title":"Artificial intelligence for drug discovery: resources, methods, and applications","volume":"31","author":"Chen","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177103_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/kinasesphosphatases1020008","article-title":"Recent advancements in computational drug design algorithms through machine learning and optimization","volume":"1","author":"Choudhuri","year":"2023","journal-title":"Kinases and Phosphatases"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41467-019-13803-0","article-title":"Interpreting pathways to discover cancer driver genes with Moonlight","volume":"11","author":"Colaprico","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2024.177103_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-0716-1787-8_14","article-title":"Artificial intelligence and quantum computing as the next pharma disruptors","volume":"2390","author":"Cova","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2024.177103_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2024.1305741","article-title":"De novo drug design through artificial intelligence: an introduction","volume":"3","author":"Crucitti","year":"2024","journal-title":"Frontiers in Hematology"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib22","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","article-title":"Machine learning in drug discovery: a review","volume":"55","author":"Dara","year":"2022","journal-title":"Artif. Intell. Rev."},{"key":"10.1016\/j.ejphar.2024.177103_bib23","first-page":"153","article-title":"Chapter 6 - artificial intelligence in systems biology","volume":"49","author":"Dasgupta","year":"2023"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1145\/1327452.1327492","article-title":"MapReduce: simplified data processing on large clusters","volume":"51","author":"Dean","year":"2008","journal-title":"Commun. ACM"},{"key":"10.1016\/j.ejphar.2024.177103_bib25","article-title":"Advancing genome editing with artificial intelligence: opportunities, challenges, and future directions","volume":"11","author":"Dixit","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177103_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051496","article-title":"Drug design-past, present, future","volume":"27","author":"Doytchinova","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2024.177103_bib27","series-title":"Proceedings of the 28th International Conference on Neural Information Processing Systems - Volume 2","first-page":"2224","article-title":"Convolutional networks on graphs for learning molecular fingerprints","author":"Duvenaud","year":"2015"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41573-020-0087-3","article-title":"Improving target assessment in biomedical research: the GOT-IT recommendations","volume":"20","author":"Emmerich","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.177103_bib29","series-title":"Pharmacometrics: the Science of Quantitative Pharmacology","author":"Ette","year":"2007"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177103_bib30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11030-022-10489-3","article-title":"Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system","volume":"27","author":"Gautam","year":"2023","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/minf.201501008","article-title":"Deep learning in drug discovery","volume":"35","author":"Gawehn","year":"2016","journal-title":"Mol Inform"},{"issue":"6","key":"10.1016\/j.ejphar.2024.177103_bib32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized medicine: motivation, challenges, and progress","volume":"109","author":"Goetz","year":"2018","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab437","article-title":"Challenges and opportunities in network-based solutions for biological questions","volume":"23","author":"Guo","year":"2022","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.ejphar.2024.177103_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107051","article-title":"Perspective of artificial intelligence in healthcare data management: a journey towards precision medicine","volume":"162","author":"Gupta","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol. Divers."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177103_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22121","article-title":"Artificial intelligence utility for drug development: ChatGPT and beyond","volume":"85","author":"Gurwitz","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177103_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ph16091259","article-title":"Revolutionizing medicinal chemistry: the application of artificial intelligence (AI) in early drug discovery","volume":"16","author":"Han","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.ejphar.2024.177103_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100577","article-title":"A computational toxicology approach to screen the hepatotoxic ingredients in traditional Chinese medicines: polygonum multiflorum thunb as a case study","volume":"9","author":"He","year":"2019","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177103_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/omi.2015.0020","article-title":"The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders","volume":"19","author":"Higdon","year":"2015","journal-title":"OMICS"},{"key":"10.1016\/j.ejphar.2024.177103_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijin.2022.05.002","article-title":"Significance of machine learning in healthcare: features, pillars and applications","volume":"3","author":"Javaid","year":"2022","journal-title":"International Journal of Intelligent Networks"},{"key":"10.1016\/j.ejphar.2024.177103_bib41","series-title":"Computer Vision \u2013 ECCV 2018: 15th European Conference, Munich, Germany, September 8\u201314, 2018, Proceedings, Part XIV","first-page":"625","article-title":"DeepVS: a deep learning based video saliency prediction approach","author":"Jiang","year":"2018"},{"issue":"9","key":"10.1016\/j.ejphar.2024.177103_bib42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/17460441.2021.1909567","article-title":"Artificial intelligence in drug discovery: recent advances and future perspectives","volume":"16","author":"Jim\u00e9nez-Luna","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.177103_bib43","series-title":"2011 5th International Conference on Application of Information and Communication Technologies (AICT)","article-title":"Cloud computing learning","author":"Kalagiakos","year":"2011"},{"issue":"6","key":"10.1016\/j.ejphar.2024.177103_bib44","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/jm061389p","article-title":"Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening","volume":"50","author":"Kellenberger","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177103_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2023.1227091","article-title":"Artificial intelligence in clinical medicine: catalyzing a sustainable global healthcare paradigm","volume":"6","author":"Krishnan","year":"2023","journal-title":"Front Artif Intell"},{"key":"10.1016\/j.ejphar.2024.177103_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2021.746712","article-title":"Machine learning for causal inference in biological networks: perspectives of this challenge","volume":"1","author":"Lecca","year":"2021","journal-title":"Frontiers in Bioinformatics"},{"issue":"22","key":"10.1016\/j.ejphar.2024.177103_bib47","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1109\/MWC.2018.1700192","article-title":"Marine wireless big data: efficient transmission, related applications, and challenges","volume":"25","author":"Li","year":"2018","journal-title":"IEEE Wireless Commun."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177103_bib49","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.drudis.2021.06.009","article-title":"AI-based language models powering drug discovery and development","volume":"26","author":"Liu","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2011.01.010","article-title":"In vitro-in vivo correlation: perspectives on model development","volume":"418","author":"Lu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2024.177103_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107550","article-title":"Molecular imaging of inflammation - current and emerging technologies for diagnosis and treatment","volume":"211","author":"MacRitchie","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/psp4.12049","article-title":"Good practices in model-informed drug discovery and development: practice, application, and documentation","volume":"5","author":"Marshall","year":"2016","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"16","key":"10.1016\/j.ejphar.2024.177103_bib53","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1021\/acs.jmedchem.0c00452","article-title":"Machine learning on DNA-encoded libraries: a new paradigm for hit finding","volume":"63","author":"McCloskey","year":"2020","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177103_bib54","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.drudis.2021.05.019","article-title":"De novo molecular design and generative models","volume":"26","author":"Meyers","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.ejphar.2024.177103_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103737","article-title":"Causal inference in drug discovery and development","volume":"28","author":"Michoel","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.ejphar.2024.177103_bib56","first-page":"230","article-title":"A study on evolution of data in traditional RDBMS to big data analytics","volume":"4","author":"Mohanty","year":"2015","journal-title":"International Journal of Advanced Research in Computer and Communication Engineering"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177103_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177103_bib58","first-page":"447","article-title":"Biotech R&D spend jumps by more than 15","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.177103_bib59","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2147\/DDDT.S424991","article-title":"The coming of age of AI\/ML in drug discovery, development, clinical testing, and manufacturing: the FDA perspectives","volume":"17","author":"Niazi","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"issue":"34","key":"10.1016\/j.ejphar.2024.177103_bib60","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1021\/acs.jpcb.2c04346","article-title":"AlphaFold, artificial intelligence (AI), and allostery","volume":"126","author":"Nussinov","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejphar.2024.177103_bib61","series-title":"Chemoinformatics and Bioinformatics in the Pharmaceutical Sciences","first-page":"207","article-title":"Chapter 7 - chem-bioinformatic approach for drug discovery: in silico screening of potential antimalarial compounds","author":"Ojha","year":"2021"},{"key":"10.1016\/j.ejphar.2024.177103_bib62","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jconrel.2022.11.014","article-title":"Application of machine learning techniques to the analysis and prediction of drug pharmacokinetics","volume":"352","author":"Ota","year":"2022","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib63","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.imed.2021.10.001","article-title":"Artificial intelligence and machine learning in drug discovery and development","volume":"2","author":"Patel","year":"2022","journal-title":"Intelligent Medicine"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2024.177103_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.565644","article-title":"Molecular sets (MOSES): a benchmarking platform for molecular generation models","volume":"11","author":"Polykovskiy","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177103_bib66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/biom14030339","article-title":"Advances in AI for protein structure prediction: implications for cancer drug discovery and development","volume":"14","author":"Qiu","year":"2024","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.ejphar.2024.177103_bib68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12032-022-01711-1","article-title":"Artificial intelligence and machine learning in precision and genomic medicine","volume":"39","author":"Quazi","year":"2022","journal-title":"Med. Oncol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177103_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17575","article-title":"AI in drug discovery and its clinical relevance","volume":"9","author":"Qureshi","year":"2023","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.ejphar.2024.177103_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10060951","article-title":"The AI-assisted identification and clinical efficacy of baricitinib in the treatment of COVID-19","volume":"10","author":"Richardson","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ejphar.2024.177103_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","article-title":"Physiologically-based pharmacokinetics in drug development and regulatory science","volume":"51","author":"Rowland","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s43094-024-00632-2","article-title":"Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China","volume":"10","author":"Sampene","year":"2024","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177103_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrd.2017.232","article-title":"Automating drug discovery","volume":"17","author":"Schneider","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.177103_bib74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-030-16391-4_11","article-title":"Artificial intelligence and personalized medicine","volume":"178","author":"Schork","year":"2019","journal-title":"Cancer Treat Res."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","article-title":"Generating focused molecule libraries for drug discovery with recurrent neural networks","volume":"4","author":"Segler","year":"2018","journal-title":"ACS Cent. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib76","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11030-021-10326-z","article-title":"Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries","volume":"26","author":"Selvaraj","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejphar.2024.177103_bib77","series-title":"Nature-Inspired Intelligent Computing Techniques in Bioinformatics","first-page":"223","article-title":"Role of nature-inspired intelligence in genomic diagnosis of antimicrobial resistance","author":"Sharma","year":"2023"},{"issue":"8","key":"10.1016\/j.ejphar.2024.177103_bib78","article-title":"Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177103_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1568","article-title":"Machine learning in drug design: use of artificial intelligence to explore the chemical structure\u2013biological activity relationship","volume":"12","author":"Staszak","year":"2022","journal-title":"WIREs Computational Molecular Science"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177103_bib80","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.xphs.2023.01.010","article-title":"Machine learning for pharmacokinetic\/pharmacodynamic modeling","volume":"112","author":"Tang","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2024.177103_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2024.1336025","article-title":"Machine learning in toxicological sciences: opportunities for assessing drug toxicity","volume":"4","author":"Tonoyan","year":"2024","journal-title":"Frontiers in Drug Discovery"},{"key":"10.1016\/j.ejphar.2024.177103_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135517","article-title":"Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design","volume":"1286","author":"Tripathi","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib83","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s11030-021-10256-w","article-title":"Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery","volume":"25","author":"Tripathi","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejphar.2024.177103_bib84","series-title":"Computational Intelligence Methods in COVID-19: Surveillance, Prevention, Prediction and Diagnosis","first-page":"273","article-title":"Computational intelligence in drug repurposing for COVID-19","author":"Tripathi","year":"2021"},{"issue":"14","key":"10.1016\/j.ejphar.2024.177103_bib85","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1080\/07391102.2022.2112621","article-title":"Identification of a promising inhibitor from Illicium verum (star anise) against the main protease of SARS-CoV-2: insights from the computational study","volume":"41","author":"Tripathi","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejphar.2024.177103_bib86","series-title":"Skin Aging & Cancer: Ambient UV-R Exposure","first-page":"101","article-title":"Bioinformatics in skin cancer: a system biology approach to understanding the molecular mechanisms and it's regulations","author":"Tripathi","year":"2019"},{"key":"10.1016\/j.ejphar.2024.177103_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ailsci.2022.100045","article-title":"Recent advances and application of generative adversarial networks in drug discovery, development, and targeting","volume":"2","author":"Tripathi","year":"2022","journal-title":"Artificial Intelligence in the Life Sciences"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib88","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021","journal-title":"Nature Reviews Methods Primers"},{"issue":"6","key":"10.1016\/j.ejphar.2024.177103_bib89","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib90","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/med.21764","article-title":"Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: state-of-the-arts and future directions","volume":"41","author":"Vatansever","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"10","key":"10.1016\/j.ejphar.2024.177103_bib91","article-title":"Artificial intelligence's impact on drug discovery and development from bench to bedside","volume":"15","author":"Vidhya","year":"2023","journal-title":"Cureus"},{"issue":"20","key":"10.1016\/j.ejphar.2024.177103_bib92","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1021\/jm4011302","article-title":"Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening","volume":"56","author":"Vidler","year":"2013","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177103_bib93","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.drudis.2021.11.023","article-title":"Enhancing preclinical drug discovery with artificial intelligence","volume":"27","author":"Vijayan","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177103_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/life14020233","article-title":"Integrating artificial intelligence for drug discovery in the context of revolutionizing drug delivery","volume":"14","author":"Visan","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.ejphar.2024.177103_bib95","article-title":"AtomNet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery","author":"Wallach","year":"2015","journal-title":"arXiv preprint arXiv:1510.02855"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib96","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12859-019-3006-z","article-title":"PTPD: predicting therapeutic peptides by deep learning and word2vec","volume":"20","author":"Wu","year":"2019","journal-title":"BMC Bioinf."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177103_bib97","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acscombsci.0c00169","article-title":"Activity prediction of small molecule inhibitors for antirheumatoid arthritis targets based on artificial intelligence","volume":"22","author":"Xing","year":"2020","journal-title":"ACS Comb. Sci."},{"issue":"87","key":"10.1016\/j.ejphar.2024.177103_bib98","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1039\/C6CC04938A","article-title":"Discovery of a VHL and HIF1\u03b1 interaction inhibitor with in vivo angiogenic activity via structure-based virtual screening","volume":"52","author":"Yang","year":"2016","journal-title":"Chem. Commun."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177103_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.aichem.2023.100011","article-title":"Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity","volume":"1","author":"Yang","year":"2023","journal-title":"Artificial Intelligence Chemistry"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-023-01381-z","article-title":"AlphaFold2 and its applications in the fields of biology and medicine","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177103_bib101","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177103_bib102","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177103_bib103","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/S2589-7500(20)30192-8","article-title":"Artificial intelligence in COVID-19 drug repurposing","volume":"2","author":"Zhou","year":"2020","journal-title":"The Lancet Digital Health"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177103_bib104","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/jm4017174","article-title":"Rapid identification of Keap1\u2013Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search","volume":"57","author":"Zhuang","year":"2014","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T01:29:28Z","timestamp":1733621368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":104,"alternative-id":["S0014299924007933"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177103","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unleashing the future: The revolutionary role of machine learning and artificial intelligence in drug discovery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177103"}}